Skip to menu Skip to content Skip to footer

2014

Journal Article

Comparison and evaluation of immobilization methods for preparing bacterial probes using acidophilic bioleaching bacteria Acidithiobacillus thiooxidans for AFM studies

Diao, Mengxue, Taran, Elena, Mahler, Stephen M. and Nguyen, Anh V. (2014). Comparison and evaluation of immobilization methods for preparing bacterial probes using acidophilic bioleaching bacteria Acidithiobacillus thiooxidans for AFM studies. Journal of Microbiological Methods, 102, 12-14. doi: 10.1016/j.mimet.2014.04.004

Comparison and evaluation of immobilization methods for preparing bacterial probes using acidophilic bioleaching bacteria Acidithiobacillus thiooxidans for AFM studies

2014

Conference Publication

The Monoclonal Antibody 3C12C, Targeting CD83 Is a T Cell Sparing, Potential New Immunosuppressive Agent

Hart, D, Verma, N., Seldon, T, Sheng, Y., Pryor, R., Palkova, A., Findova, M., Jones, M., Munro, T., Mahler, S., Braet, K., Barnard, R., Marks, J., Coley, A., Fan, F., Zhou, Y., Vu, P, Lo, K., Shahin, K., Elgundi, Z., Silveira, P., Fromm, P., Clark, G., Larsen, S., Bradstock, K. and Munster, D. (2014). The Monoclonal Antibody 3C12C, Targeting CD83 Is a T Cell Sparing, Potential New Immunosuppressive Agent. 2014 World Transplant Congress, San Francicso Ca, 26 - 31 July 2014. Malden, MA United States: Wiley-Blackwell Publishing, Inc.. doi: 10.1111/ajt.12888

The Monoclonal Antibody 3C12C, Targeting CD83 Is a T Cell Sparing, Potential New Immunosuppressive Agent

2013

Other Outputs

Anti-CD83 antibodies and use thereof

Seldon, T. A., Munster, D. J., Hart, D. N., Jones, M. L., Munro, T. P., Mahler, S. M., Zhou, Y. and Marks, D. (2013). Anti-CD83 antibodies and use thereof.

Anti-CD83 antibodies and use thereof

2012

Book Chapter

Evolution of proteomic methods for analysis of complex biological samples - implications for personalized medicine.

Nouwens, Amanda and Mahler, Stephen (2012). Evolution of proteomic methods for analysis of complex biological samples - implications for personalized medicine.. Integrative Proteomics. (pp. 29-43) edited by Hon-Chiu Eastwood Leung, Tsz-Kwong Man and Ricardo J. Flores. Croatia: InTech. doi: 10.5772/29613

Evolution of proteomic methods for analysis of complex biological samples - implications for personalized medicine.

2011

Journal Article

Bridging the gap: Facilities and technologies for development of early stage therapeutic mAb candidates

Munro, Trent P., Mahler, Stephen M., Huang, Edwin P., Chin, David Y. and Gray, Peter P. (2011). Bridging the gap: Facilities and technologies for development of early stage therapeutic mAb candidates. mAbs, 3 (5), 440-452. doi: 10.4161/mabs.3.5.16968

Bridging the gap: Facilities and technologies for development of early stage therapeutic mAb candidates

2011

Journal Article

Clonal selection of high producing, stably transfected HEK293 cell lines utilizing modified, high-throughput FACS screening

Song, Michael, Raphaelli, Kristin, Jones, Martina L., Aliabadi-Zadeh, Khosrow, Leung, Kar Man, Crowley, David, Hughes, Benjamin, Mahler, Stephen, Gray, Peter P., Huang, Edwin P. and Chin, David Y. (2011). Clonal selection of high producing, stably transfected HEK293 cell lines utilizing modified, high-throughput FACS screening. Journal of Chemical Technology and Biotechnology, 86 (7), 935-941. doi: 10.1002/jctb.2618

Clonal selection of high producing, stably transfected HEK293 cell lines utilizing modified, high-throughput FACS screening

2011

Journal Article

Analytical strategies for assessing comparability of biosimilars

Falconer, Robert J., Jackson-Matthews, Dianne and Mahler, Stephen M. (2011). Analytical strategies for assessing comparability of biosimilars. Journal of Chemical Technology and Biotechnology, 86 (7), 915-922. doi: 10.1002/jctb.2629

Analytical strategies for assessing comparability of biosimilars

2011

Journal Article

Biologics and biosimilars: emerging technologies driving global opportunity

Mahler, Stephen and Gray, Peter (2011). Biologics and biosimilars: emerging technologies driving global opportunity. Journal of Chemical Technology & Biotechnology, 86 (7), 893-894. doi: 10.1002/jctb.2684

Biologics and biosimilars: emerging technologies driving global opportunity

2011

Book Chapter

C15 disease-modifying antirheumatic drugs

Pile, Kevin D., Graham, Garry G., Mahler, Stephen M. and Day, Richard O. (2011). C15 disease-modifying antirheumatic drugs. Principles of immunopharmacology. (pp. 585-619) edited by Frans P. Nijkamp and Michael J. Parnham. Basel, Switzerland: Springer. doi: 10.1007/978-3-0346-0136-8_30

C15 disease-modifying antirheumatic drugs

2010

Journal Article

Disease-specific, neurosphere-derived cells as models for brain disorders

Matigian, N, Abrahamsen, G, Sutharsan, R, Cook, AL, Vitale, AM, Nouwens, A, Bellette, B, An, JY, Anderson, M, Beckhouse, AG, Bennebroek, M, Cecil, R, Chalk, AM, Cochrane, J, Fan, YJ, Feron, F, McCurdy, R, McGrath, JJ, Murrell, W, Perry, C, Raju, J, Ravishankar, S, Silburn, PA, Sutherland, GT, Mahler, S, Mellick, GD, Wood, SA, Sue, CM, Wells, CA and Mackay-Sim, A (2010). Disease-specific, neurosphere-derived cells as models for brain disorders. Disease Models and Mechanisms, 3 (11-12), 785-798. doi: 10.1242/dmm.005447

Disease-specific, neurosphere-derived cells as models for brain disorders

2010

Journal Article

A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies

Jones, Martina L., Seldon, Therese, Smede, Matthew, Linville, Ashleigh, Chin, David Y., Barnard, Ross, Mahler, Stephen M., Munster, David, Hart, Derek, Gray, Peter P. and Munro, Trent P. (2010). A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies. Journal of Immunological Methods, 354 (1-2), 85-90. doi: 10.1016/j.jim.2010.02.001

A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies

2009

Journal Article

Evidence of heterogeneity in the antibody response against the platelet antigen 3a; recognition of an 11-mer peptide carrying the HPA-3a polymorphic determinant

de Leon, EJ, Yuan, FF, Pearson, H, Marquis, CP and Mahler, SM (2009). Evidence of heterogeneity in the antibody response against the platelet antigen 3a; recognition of an 11-mer peptide carrying the HPA-3a polymorphic determinant. VOX SANGUINIS, 96 (3), 252-255. doi: 10.1111/j.1423-0410.2008.01146.x

Evidence of heterogeneity in the antibody response against the platelet antigen 3a; recognition of an 11-mer peptide carrying the HPA-3a polymorphic determinant

2009

Journal Article

A sensitive and specific ELISA detects methionine sulfoxide-containing apolipoprotein A-I in HDL

Wang, XS, Shao, BH, Oda, MN, Heinecke, JW, Mahler, S and Stocker, R (2009). A sensitive and specific ELISA detects methionine sulfoxide-containing apolipoprotein A-I in HDL. JOURNAL OF LIPID RESEARCH, 50 (3), 586-594. doi: 10.1194/jlr.D800042-JLR200

A sensitive and specific ELISA detects methionine sulfoxide-containing apolipoprotein A-I in HDL

2009

Conference Publication

Developing a Therapeutic Anti - Dendritic Cell Antibody to Prevent Graft Versus Host Disease

Hart, D, Seldon, T, Jones, M, Sheng, Y, Palkova, A, Cullup, H, Munro, T, Sinfield, L, Rice, AM, Wilson, J, Gray, P, Barnard, R, Mahler, S and Munster, D (2009). Developing a Therapeutic Anti - Dendritic Cell Antibody to Prevent Graft Versus Host Disease. 51st Annual Meeting of the American Society of Hematology, New Orleans LA, 5-8 December 2009. Washington, D.C.: American Society of Hematology.

Developing a Therapeutic Anti - Dendritic Cell Antibody to Prevent Graft Versus Host Disease

2008

Journal Article

BioPEGylation of Polyhydroxyalkanoates: Influence on Properties and Satellite-Stem Cell Cycle

Marcal, Helder, Wanandy, Nico S., Sanguanchaipaiwong, Vorapat, Woolnough, Catherine E., Lauto, Antonio, Mahler, Stephen M. and Foster, L. John R. (2008). BioPEGylation of Polyhydroxyalkanoates: Influence on Properties and Satellite-Stem Cell Cycle. Biomacromolecules, 9 (10), 2719-2726. doi: 10.1021/bm800418e

BioPEGylation of Polyhydroxyalkanoates: Influence on Properties and Satellite-Stem Cell Cycle

2008

Journal Article

Expression proteomics of olfactory ensheathing cells

Marcal, Helder, Sarris, Maria, Raftery, Mark J., Bhasin, Vishal, McFarland, Clive and Mahler, Stephen M. (2008). Expression proteomics of olfactory ensheathing cells. Journal of Chemical Technology And Biotechnology, 83 (4), 473-481. doi: 10.1002/jctb.1900

Expression proteomics of olfactory ensheathing cells

2008

Journal Article

In Focus: Stem cell and tissue engineering applications in regenerative medicine

Mahler, Stephen (2008). In Focus: Stem cell and tissue engineering applications in regenerative medicine. Journal of Chemical Technology and Biotechnology, 83 (4), 395-396. doi: 10.1002/jctb.1933

In Focus: Stem cell and tissue engineering applications in regenerative medicine

2008

Journal Article

The macrophage-biomaterial interface: a proteomic analysis of the conditioned medium environment

Dinnes, Donna Lee M., Marcal, Helder, Raftery, Mark J., Labow, Rosalind S. and Mahler, Stephen M. (2008). The macrophage-biomaterial interface: a proteomic analysis of the conditioned medium environment. Journal of Chemical Technology And Biotechnology, 83 (4), 482-495. doi: 10.1002/jctb.1854

The macrophage-biomaterial interface: a proteomic analysis of the conditioned medium environment

2008

Journal Article

Practical blood dendritic cell vaccination for immunotherapy of multiple myeloma

Vari F, Munster D.J., Hsu J.L., Rossetti T.R., Stephen Mahler, Gray, Peter P., Turtle C.J., Prue R.L. and Hart D.N. (2008). Practical blood dendritic cell vaccination for immunotherapy of multiple myeloma. British Journal Of Haematology, 143 (3), 374-377. doi: 10.1111/j.1365-2141.2008.07346.x

Practical blood dendritic cell vaccination for immunotherapy of multiple myeloma

2008

Journal Article

Cytotoxic activity of CD48 monoclonal antibodies against human lymphoma cells

Wei, Jiewei, Chin, David Y. and Mahler, Stephen M. (2008). Cytotoxic activity of CD48 monoclonal antibodies against human lymphoma cells. Open Biotechnology Journal, 2 (1), 219-223. doi: 10.2174/1874070700802010219

Cytotoxic activity of CD48 monoclonal antibodies against human lymphoma cells